Hematology

Top Story

NHLBI releases new strategic vision

August 28, 2016

The NHLBI announced eight objectives as part of a new strategic vision that charts the course for research in heart, lung, blood and sleep disorders into the next decade, according to a press release.

The institute had nearly 4,500 individuals from around the world offer input on critical research questions and challenges and formed its objectives based on that feedback.

In the Journals

Gene therapy superior to haploidentical HSCT for SCID-X1

August 26, 2016
Gene therapy was associated with faster T-cell reconstitution and a better long-term thymic output than partially matched hematopoietic stem cell transplantation for…

Bayer awards grants for research into hemophilia, bleeding disorders

August 24, 2016
Bayer awarded six grants to U.S. clinicians and investigators for research and educational initiatives in hemophilia and related bleeding disorders. The recipients are…
In the Journals Plus

rVIII-SingleChain appears safe, effective for severe hemophilia A

August 24, 2016
The novel therapy rVIII-SingleChain demonstrated hemostatic efficacy in surgery and controlled bleeding events in patients with severe hemophilia A, according to…
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Video
At Issue

VIDEO: Adoptive T-cell therapy poised to become ‘mainstay’ in myeloma treatment paradigm

February 16, 2016
More »
Featured
Discoveries from ASCO 2016: Breast Cancer

Discoveries from ASCO 2016: Breast Cancer

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »

NHLBI releases new strategic vision

August 28, 2016
The NHLBI announced eight objectives as part of a new strategic vision that charts the course for research in heart, lung, blood and sleep disorders…

In the Journals

Gene therapy superior to haploidentical HSCT for SCID-X1

August 26, 2016
Gene therapy was associated with faster T-cell reconstitution and a better long-term thymic output than partially matched hematopoietic stem cell…

Bayer awards grants for research into hemophilia, bleeding disorders

August 24, 2016
Bayer awarded six grants to U.S. clinicians and investigators for research and educational initiatives in hemophilia and related bleeding disorders…

In the Journals Plus

rVIII-SingleChain appears safe, effective for severe hemophilia A

August 24, 2016
The novel therapy rVIII-SingleChain demonstrated hemostatic efficacy in surgery and controlled bleeding events in patients with severe hemophilia A…

In the Journals Plus

Corticosteroids, immune globulin induce similar platelet count responses for ITP during pregnancy

August 23, 2016
Pregnant women with immune thrombocytopenia had similar maternal platelet count responses whether treated with IV immune globulin or corticosteroids…

In the Journals Plus

Anticoagulation therapy decreases proximal DVT and PE, increases bleeding after calf DVT

August 21, 2016
Therapeutic anticoagulation therapy decreased already-low rates of proximal deep vein thrombosis and pulmonary embolism among patients with isolated…

In the Journals Plus

Early prophylaxis reduces risk for PE, DVT in patients with traumatic brain injury

August 19, 2016
Early initiation of venous thromboembolism prophylaxis appeared associated with decreased risk for pulmonary embolism and deep vein thrombosis in…

FDA News

FDA does not approve reversal agent for anticoagulation drugs

August 18, 2016
Portola Pharmaceuticals announced it received a complete response letter from the FDA that its reversal agent for Factor Xa inhibitor anticoagulants…

In the Journals Plus

Anticoagulation increases intracranial hemorrhage risk in patients with glioma

August 16, 2016
Patients with glioma receiving therapeutic anticoagulation had a greater than threefold risk for intracranial hemorrhage, according to the results of…

In the Journals Plus

Disseminated intravascular coagulation scores predict venous, arterial thrombosis risk in AML

August 13, 2016
Approximately 10% of newly diagnosed patients with acute myeloid leukemia will develop venous and arterial thrombosis after treatment with intensive…

More Headlines »